Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
389 studies found for:    diabetes and type 1 and open and active | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Bright 1 Bodies Weight Management Program
Condition: Diabetes Mellitus, Type 1
Intervention: Behavioral: Bright 1 Bodies
22 Recruiting A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin, Onglyza;   Drug: Dapagliflozin, Farxiga;   Drug: Glargine insulin;   Drug: Metformin XR
23 Not yet recruiting Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care
Conditions: Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1
Intervention: Device: Paired testing of blood glucose Accu-Chek®
24 Not yet recruiting Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Device: MiniMed™640G and Suspend before low;   Device: MiniMed™640G
25 Recruiting Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: insulin glargine (U300);   Drug: insulin glargine;   Drug: fast-acting insulin analogue
26 Recruiting Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions
Conditions: Diabetes Mellitus, Type I;   Adjustment of Basal Insulin Flow Rate During Physical Activity;   Adjustment of Prandial Insulin in Case of Physical Activity
Interventions: Behavioral: Usual algorithm;   Behavioral: Diabrasport algorithm;   Behavioral: Rest;   Device: Holter Glycemic Ipro2, Medtronic
27 Unknown  Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy
Condition: Treatment of Type I Diabetes Mellitus.
Intervention: Biological: Biological
28 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010);   Drug: Lixisenatide (AVE0010);   Drug: Oral anti-diabetic drugs
29 Recruiting Cross-sectional, Case Control Study of Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in Healthy
Condition: Diabetes Mellitus, Type 1
Interventions: Device: MRI including DTI , EEG, CGMS;   Behavioral: Neurocognitive tests
30 Unknown  Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study
Condition: Type 1 Diabetes
Interventions: Procedure: Isolated Pancreas Transplant;   Drug: Intensive Insulin Therapy
31 Recruiting Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Liraglutide;   Drug: Sitagliptin
32 Recruiting Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE (U300);   Drug: Insulin degludec;   Drug: GLP-1 receptor agonist;   Drug: Glimepiride;   Drug: Metformin
33 Recruiting The Mobile Diabetes Mgmt. Study With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Other: Traditional care with paper;   Device: Health-on G App. + Physician Web
34 Recruiting Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesteryl Ester Transfer Protein in Type-1 Diabetes Patients
Condition: diabète de Type 1
Intervention: Biological: Prise de sang
35 Recruiting Description of Socio-cognitive and Clinic Changes for Type 1 Diabetes Adolescents Cohort With Therapeutic Patient Education Program
Condition: Type 1 Diabetes
Intervention: Other: Questionnaires and audio-tape interviews
36 Unknown  Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)
Condition: Latent Autoimmune Diabetes in Adults LADA
Interventions: Drug: NovoMix 30;   Drug: Tablet treatment
37 Recruiting Impact of Different Types of Exercise Training on Biochemical Markers of Insulin-dependent Patients
Condition: Diabetes Mellitus, Type 1
Interventions: Other: High-intensity interval training (HIIT);   Other: Strength training (ST);   Other: ST combined with HIIT (ST+HIIT)
38 Recruiting Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010);   Drug: Insulin glargine U100 (HOE901);   Drug: Metformin
39 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/lixisenatide (HOE901/AVE0010);   Drug: Insulin glargine (HOE901);   Drug: Oral anti-diabetic drugs
40 Recruiting Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion
Condition: Type 1 Diabetes
Interventions: Drug: canagliflozin;   Other: basal interruption without canagliflozin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years